Professor Daniel Rea
Professor Rea is medical oncologist specialising in breast cancer research and treatment. He is the chief investigator for several large multicentre national and International clinical trials in early breast cancer – TEAM, aTTom, ROSCO, NOSTRA and Neoexel. He is a member of the trial management groups for the OPTIMA, LORIS, Plasma-MATCH, SMALL and AURORA trials.
He is the Chair of the NCRI Breast Clinical Studies Group supporting the development of the national breast clinical trials portfolio and leading on breast cancer research strategy for the NCRI. He is deputy director of the Cancer Research Clinical Trials Unit in Birmingham with responsibility for the adult clinical trials programme. He is a member of the United Kingdom Breast Cancer Group (UKBCG) steering committee.
Professor Rea provides medical oncology services to the breast unit at University Hospital Birmingham where he runs a clinical trials focused practice. He has an active teaching role within the University, teaching and examining undergraduate and postgraduate courses.